经过10毫克甲基酸盐的急性给药后的驾驶表现和眼睛活动:一项随机,双盲,安慰剂控制的随机研究
Blair Aitken1, Luke A Downey1,2, Serah Rose1
1Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia.
一次10毫克的甲基胺剂量通过减少车道编织和速度变化,改善了健康成年人的驾驶性能. 这种兴奋剂在模拟驾驶任务期间不会对视觉扫描行为产生负面影响.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 人类因素工程 人类因素工程
背景情况:
- 甲基胺是一种常见的ADHD治疗方法,有可能被滥用.
- 它对健康个体驾驶等安全敏感任务的影响尚不清楚.
研究的目的:
- 为了研究10毫克的甲基胺剂量对健康成年人的驾驶表现和目光行为的急性影响.
主要方法:
- 25名健康成年人完成了两次模拟高速公路驾驶,同时监测了眼睛的运动.
- 驾驶性能指标包括横向位置和速度变化.
- 视觉扫描效率使用眼睛指标进行评估.
主要成果:
- 甲基化物通过减少车道编织和速度变化,显著改善了驾驶.
- 观察到固定时间的缩短.
- 与视觉扫描相关的其他眼睛指标保持不变.
结论:
- 一次10毫克的甲基胺剂量可以减轻单调驾驶的性能下降.
- 它似乎对低至中等认知需求驱动任务中的视觉扫描没有不利影响.
- 需要对不同剂量和驾驶条件进行进一步的研究.
更多相关视频
11:12Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Blind Procedures
